Takeda lung cancer drug gets European panel nod
Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States.
from Reuters: Health News https://reut.rs/2QOzvgz
http://bit.ly/2zwRqiM